Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Anti-Inflammatory Add-On May Be Beneficial for Depression
Draft Recommendation Promotes Screening Women for Anxiety
Depressive Symptoms May Up Risk for Death in HIV+ Veterans
Reduction in Autism Diagnoses Observed With DSM-5
Can Maternal Diet Affect the Risk of ADHD Development in Offspring?
Rykindo NDA for Schizophrenia, Bipolar Disorder Submitted to FDA
Nonsurgical Brain Stimulation Beneficial in Major Depressive Episodes
Investigational Agent for Major Depressive Disorder Gets FDA’s Breakthrough Designation
Stimulation Device for MDD Cleared for Much Shorter Treatment Session
Prenatal Pesticide Exposure Linked to Increased Risk for Autism
Risk of New-Onset Psychosis Examined Among ADHD Patients Treated With Stimulants
Zulresso Approved as First Treatment for Postpartum Depression
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
FDA to Review Lemborexant NDA for Treatment of Insomnia
Conversion From Sleep Disorder to Neurodegeneration Studied
Rapastinel Fails to Meet Primary Endpoint in Phase 3 Adjunctive MDD Trials
Spravato Nasal Spray Approved for Treatment-Resistant Depression
Can a Physician Be Held Liable When a Patient Commits Suicide?
